Источники

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed., text rev. Washington, DC: American Psychiatric Association Publishing; 2022.

2. National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline NG87. London: NICE; 2018, updated 2019.

3. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry. 2019;56:14–34. doi:10.1016/j.eurpsy.2018.11.001.

4. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021;128:789–818. doi:10.1016/j.neubiorev.2021.01.022.

5. Fu X, Wu W, Wu Y, et al. Adult ADHD and comorbid anxiety and depressive disorders: a review of etiology and treatment. Frontiers in Psychiatry. 2025;16:1597559. doi:10.3389/fpsyt.2025.1597559.

6. Salvi V, Ribuoli E, Servasi M, Orsolini L, Volpe U. ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications. Medicina (Kaunas). 2021;57(5):466. doi:10.3390/medicina57050466.

7. Pleshkevich M, Broomfield R, Burton S, et al. Attention deficit/hyperactivity disorder diagnosis in adulthood: Prevalence and predictive utility of neuropsychological scales. Archives of Clinical Neuropsychology. 2026. doi:10.1093/arclin/acag057.

8. Woloszyn M, Hernandez-Vallant A, Palladino NT, et al. Perceived Stress Is Associated With Lifetime ADHD Symptom Reporting Over and Above Anxiety and Depression: Implications for Psychiatric Evaluation and Treatment. Journal of Psychiatric Practice. 2026;32(2):64–69. doi:10.1097/PRA.0000000000000909.